Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Ephraim P Hochberg"'
Autor:
Eduardo Hariton MD, MBA, Pietro Bortoletto MD, Eden R Cardozo MD, Ephraim P Hochberg MD, Mary E Sabatini MD, PhD
Publikováno v:
Journal of Patient Experience, Vol 3 (2016)
Purpose: To determine the impact of the establishment of a dedicated oncofertility clinic on the frequency of patient referrals for fertility preservation (FP) consultation and the time from patient referral to consultation. Methods: A retrospective
Externí odkaz:
https://doaj.org/article/3d31db2e142244e48d539a79d254d527
Autor:
Rameen Beroukhim, Ming Lin, Yuhyun Park, Ke Hao, Xiaojun Zhao, Levi A Garraway, Edward A Fox, Ephraim P Hochberg, Ingo K Mellinghoff, Matthias D Hofer, Aurelien Descazeaud, Mark A Rubin, Matthew Meyerson, Wing Hung Wong, William R Sellers, Cheng Li
Publikováno v:
PLoS Computational Biology, Vol 3, Iss 2 (2007)
Externí odkaz:
https://doaj.org/article/5628f1e14b1c45c8b51800b6f70076a5
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
Autor:
Rameen Beroukhim, Ming Lin, Yuhyun Park, Ke Hao, Xiaojun Zhao, Levi A Garraway, Edward A Fox, Ephraim P Hochberg, Ingo K Mellinghoff, Matthias D Hofer, Aurelien Descazeaud, Mark A Rubin, Matthew Meyerson, Wing Hung Wong, William R Sellers, Cheng Li
Publikováno v:
PLoS Computational Biology, Vol 2, Iss 5, p e41 (2006)
Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the evolution of epithelial and mesenchymal tumors. Identification of these regions usually relies on genotyping tumor and counterpart normal DNA and noti
Externí odkaz:
https://doaj.org/article/ce4f67892b384292819d1424c67e2ab9
Autor:
Russell J.H. Ryan, Jelena Petrovic, Dylan M. Rausch, Yeqiao Zhou, Caleb A. Lareau, Michael J. Kluk, Amanda L. Christie, Winston Y. Lee, Daniel R. Tarjan, Bingqian Guo, Laura K.H. Donohue, Shawn M. Gillespie, Valentina Nardi, Ephraim P. Hochberg, Stephen C. Blacklow, David M. Weinstock, Robert B. Faryabi, Bradley E. Bernstein, Jon C. Aster, Warren S. Pear
Publikováno v:
Cell Reports, Vol 21, Iss 3, Pp 784-797 (2017)
Gain-of-function Notch mutations are recurrent in mature small B cell lymphomas such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), but the Notch target genes that contribute to B cell oncogenesis are largely unknown. We perfor
Externí odkaz:
https://doaj.org/article/38f5e0dad5ea46838f521f8dde4cb919
Autor:
Bradley E. Bernstein, Ephraim P. Hochberg, Aliyah R. Sohani, Valentina Nardi, Charles B. Epstein, Shawn Gillespie, Robbyn Issner, Jasleen Kaur, M. Joel Cotton, Holly Whitton, Yotam Drier, Russell J.H. Ryan
Supplementary Table S4. Sequences of oligonucleotides used for qRT-PCR, RT-PCR, and 3C.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210e5fa223cb63f4621df3127adc77c8
https://doi.org/10.1158/2159-8290.22529934
https://doi.org/10.1158/2159-8290.22529934
Autor:
Bradley E. Bernstein, Ephraim P. Hochberg, Aliyah R. Sohani, Valentina Nardi, Charles B. Epstein, Shawn Gillespie, Robbyn Issner, Jasleen Kaur, M. Joel Cotton, Holly Whitton, Yotam Drier, Russell J.H. Ryan
Supplementary Table S1. Clinical and diagnostic information on lymphoma cases. Supplementary Table S2. Rearrangements detected by PEAR-ChIP in 14 lymphoma primary samples and 8 lymphoma cell lines. Supplementary Table S3. Detection of large-scale rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3b019fe6ebc031d5b755dad88ed22bb
https://doi.org/10.1158/2159-8290.22529937
https://doi.org/10.1158/2159-8290.22529937
Autor:
Bradley E. Bernstein, Ephraim P. Hochberg, Aliyah R. Sohani, Valentina Nardi, Charles B. Epstein, Shawn Gillespie, Robbyn Issner, Jasleen Kaur, M. Joel Cotton, Holly Whitton, Yotam Drier, Russell J.H. Ryan
Supplementary Figure S1. H3K27ac ChIP-Seq tracks and position of rearrangements of possible oncogenic significance detected by PEAR-ChIP. Red bars join discordant intra-chromosomal read pairs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900fa1aa5c257675d713a4d2e2b6f25e
https://doi.org/10.1158/2159-8290.22529955.v1
https://doi.org/10.1158/2159-8290.22529955.v1
Autor:
Bradley E. Bernstein, Ephraim P. Hochberg, Aliyah R. Sohani, Valentina Nardi, Charles B. Epstein, Shawn Gillespie, Robbyn Issner, Jasleen Kaur, M. Joel Cotton, Holly Whitton, Yotam Drier, Russell J.H. Ryan
Supplementary Methods, Figure Legends, Table Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02bed27b2d1ea518a8548f0942f974d8
https://doi.org/10.1158/2159-8290.22529940.v1
https://doi.org/10.1158/2159-8290.22529940.v1
Autor:
Jennifer R. Brown, Donna Neuberg, Lillian Werner, Robert P. Hasserjian, Philippe Armand, Eric D. Jacobsen, Ann S. LaCasce, David C. Fisher, Kathleen M. Leahy, Karen K. Ballen, Ephraim P. Hochberg, Tak Takvorian, Eyal C. Attar, Philip C. Amrein
Purpose: Chronic lymphocytic leukemia (CLL) cells treated with dasatinib in vitro undergo apoptosis via inhibition of Lyn kinase. Thus, in this study we tested the activity of dasatinib in patients with relapsed CLL.Experimental Design: Patients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aadc7708d1fdfb43f7b4346bc6f08f7b
https://doi.org/10.1158/1078-0432.c.6518805.v1
https://doi.org/10.1158/1078-0432.c.6518805.v1
Autor:
Jennifer R. Brown, Donna Neuberg, Lillian Werner, Robert P. Hasserjian, Philippe Armand, Eric D. Jacobsen, Ann S. LaCasce, David C. Fisher, Kathleen M. Leahy, Karen K. Ballen, Ephraim P. Hochberg, Tak Takvorian, Eyal C. Attar, Philip C. Amrein
Supplementary Figure S1; Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec58e26d8591bea031bc9e1301124c0
https://doi.org/10.1158/1078-0432.22441947.v1
https://doi.org/10.1158/1078-0432.22441947.v1